Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/48491
Title: Peripheral Immune Remodeling After Spinal Cord Injury
Authors: VEENINGEN, Naomi 
ANE KOURI, Ana Laura 
PUES, Astrid 
RUBIO, Serina 
FRAUSSEN, Judith 
IOANNOU, Chara 
MARTENS, Dries 
Van Laake-Geelen, Charlotte C. M.
Deckers , Jens
Cornips, Erwin M. J.
BAMPS, Sven 
GYSEMBERG, Griet 
VAN BROECKHOVEN, Jana 
HELLINGS, Niels 
SLAETS, Leen 
Issue Date: 2026
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Source: Neurology: Neuroimmunology & neuroinflammation, 13 (2) (Art N° e200544)
Abstract: Background and ObjectivesSpinal cord injury (SCI) is associated with severe immunologic changes, such as SCI-induced immune deficiency syndrome, which heightens susceptibility to infections. However, the immune components underlying this immune reorganization remain poorly defined. This study aimed to characterize immune remodeling in patients with SCI across different time points postinjury.MethodsHigh-dimensional flow cytometric profiling was performed on peripheral blood samples from patients with SCI in a cross-sectional observational study to assess immune changes at different postinjury time points. Patients in the subacute phase (22-67 days of postinjury [dpi]) and chronic phase (>= 365 dpi) were compared with healthy, sex-matched, and age-matched controls.ResultsAlterations in the T-cell and natural killer (NK) cell compartments were observed, particularly in the subacute phase postinjury. Memory T cells and NK cells showed elevated expression of the NAD+ metabolizing enzyme CD38 and immune checkpoint molecules, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1), indicating immune activation and possible exhaustion. Coexpression of CD38 and CTLA-4 on T cells was rare, suggesting distinct activation and inhibitory states. In chronic patients, we observed decreased frequencies of NK cells with no substantial changes in T cells and B cells. Notably, changes in CD38, CTLA-4, and PD-1 were no longer found in patients in the chronic phase.DiscussionThese findings reveal noteworthy changes in immune cell activation and exhaustion markers that may contribute to immune vulnerability after SCI, offering novel insights into potential therapeutic targets, such as NAD+ metabolism and immune checkpoint modulation.
Notes: Hellings, N (corresponding author), Hasselt Univ, Biomed Res Inst, Dept Immunol & Infect, Diepenbeek, Belgium.; Hellings, N (corresponding author), Univ MS Ctr UMSC, Hasselt Pelt, Belgium.
Document URI: http://hdl.handle.net/1942/48491
ISSN: 2332-7812
e-ISSN: 2332-7812
DOI: 10.1212/NXI.0000000000200544
ISI #: 001673686600001
Rights: 2026 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
NXI.pdfPublished version860.8 kBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.